EUCTR2017-000863-34-NL进行中（未招募）1 期
Curing chronic wounds with fibrin
未提供0 个研究点目标入组 33 人开始时间: 2017年4月3日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Chronic, non-infected wound on either the foot or leg (Texas classification grade 1 or 2, stage A or C) that is non-respondent to treatment for at least 6 weeks.
- •-The size of the wounds must be between 1-20 cm2.
- •-Older than 18 years.
- •-BMI <40 kg/m2.
- •-HbA1c <10%.
- •-Willing to participate in our study.
- •-Signed informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 16
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 17
排除标准
- •- Patient suffers from osteomyelitis, cellulitis, gangrene or any other type of infection on the investigated leg.
- •- Patient is known with an anaphylactic / severe systemic reaction towards human blood products.
- •- Patient is known with alcohol or drug abuse.
- •- It is impossible to correctly inform the patient (language barrier, mental problems).
研究者
相似试验
招募中
2 期
Curing chronic wounds with fibrin.Chronische wondenChronic woundsulcers1001265310014982NL-OMON50490Erasmus MC, Universitair Medisch Centrum Rotterdam33
已完成
不适用
Treatment of chronic wounds using FN coating wound bed combined with autologous skin cell suspension and Split-thickness skin grafting: A randomized controlled trialJPRN-UMIN000032618The First Affiliated Hospital of Sun Yat-sen University Department of Burn Surgery102
进行中（未招募）
1 期
se of fibrinogen in the treatment of bleeding in thrombopenic patients after intensive chemotherapy refractory to platelet transfusio- Major patient- Patient with malignant hemopathy requiring intensive chemotherapy, autologous or allogeneic hematopoietic stem cell transplantation- Grade = 1 hemorrhagic symptom according to WHO - WHO classification- Body weight between 38 and 78 kg- Patient presenting with a platelet refractory state defined according to the Corrected Count Increment (CCI)- Patient affiliated to a social security schemeMedDRA version: 21.1Level: LLTClassification code 10066481Term: Hematological malignancySystem Organ Class: 100000004864EUCTR2021-000990-10-FRInstitut de Cancérologie Lucien Neuwirth10
已完成
不适用
Application of fibrinogen concentrate (Fibrinogen HT) to uncontrollable massive bleedingMassive bleeding during 1)Pregnancy and delivery 2)Cardiovascular surgery 3)Gastrointestinal (including hepato-biliary-pancreatic) surgeryJPRN-UMIN000022666Kagoshima University Hospital, Division of blood transfusion medicine and cell therapy26
招募中
不适用
tility of autologous fibrin glue for prevention of delayed bleeding of gastric endoscopic submucosal dissection under antithrombotic therapyGastric neoplasmsJPRN-UMIN000019386Toranomon hospital20